206 related articles for article (PubMed ID: 15036557)
1. Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma.
Neufeld AH
Brain Res Bull; 2004 Feb; 62(6):455-9. PubMed ID: 15036557
[TBL] [Abstract][Full Text] [Related]
2. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure.
Shareef S; Sawada A; Neufeld AH
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2884-91. PubMed ID: 10549648
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma.
Neufeld AH; Sawada A; Becker B
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9944-8. PubMed ID: 10449799
[TBL] [Abstract][Full Text] [Related]
4. A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma.
Neufeld AH; Das S; Vora S; Gachie E; Kawai S; Manning PT; Connor JR
J Glaucoma; 2002 Jun; 11(3):221-5. PubMed ID: 12140399
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma.
Neufeld AH
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S129-35. PubMed ID: 10416755
[TBL] [Abstract][Full Text] [Related]
6. Expression of neuronal nitric oxide synthase in the retina of a rat model of chronic glaucoma.
Park SH; Kim JH; Kim YH; Park CK
Vision Res; 2007 Sep; 47(21):2732-40. PubMed ID: 17825345
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase in retina and optic nerve head of rat with increased intraocular pressure and effect of timolol.
Vidal L; Díaz F; Villena A; Moreno M; Campos JG; de Vargas IP
Brain Res Bull; 2006 Oct; 70(4-6):406-13. PubMed ID: 17027776
[TBL] [Abstract][Full Text] [Related]
8. Glaucomatous optic neuropathy: when glia misbehave.
Neufeld AH; Liu B
Neuroscientist; 2003 Dec; 9(6):485-95. PubMed ID: 14678581
[TBL] [Abstract][Full Text] [Related]
9. [Expression of nitric oxide synthase-2 in specific cells of human glaucomatous optic nerve head].
Liu B; Neufeld AH
Zhonghua Yan Ke Za Zhi; 2001 Sep; 37(5):381-3. PubMed ID: 11770412
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
11. Effect of hypercholesterolemia on inducible nitric oxide synthase expression in a rat model of elevated intraocular pressure.
Yücel I; Akar Y; Yücel G; Ciftçioğlu MA; Keleş N; Aslan M
Vision Res; 2005 Apr; 45(9):1107-14. PubMed ID: 15707919
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies.
Marcic TS; Belyea DA; Katz B
Curr Opin Ophthalmol; 2003 Dec; 14(6):353-6. PubMed ID: 14615639
[TBL] [Abstract][Full Text] [Related]
13. [Contemporary possibilities and perspectives in the treatment of glaucoma].
Czepita D
Ann Acad Med Stetin; 2005; 51(1):27-31. PubMed ID: 16496599
[TBL] [Abstract][Full Text] [Related]
14. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy.
Vorwerk CK; Gorla MS; Dreyer EB
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S142-50. PubMed ID: 10416757
[TBL] [Abstract][Full Text] [Related]
15. Disease progression and the need for neuroprotection in glaucoma management.
Varma R; Peeples P; Walt JG; Bramley TJ
Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase in the human glaucomatous optic nerve head.
Neufeld AH; Hernandez MR; Gonzalez M
Arch Ophthalmol; 1997 Apr; 115(4):497-503. PubMed ID: 9109759
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes.
de la Torre JC; Aliev G
J Cereb Blood Flow Metab; 2005 Jun; 25(6):663-72. PubMed ID: 15703700
[TBL] [Abstract][Full Text] [Related]
19. Melatonin: a novel neuroprotectant for the treatment of glaucoma.
Belforte NA; Moreno MC; de Zavalía N; Sande PH; Chianelli MS; Keller Sarmiento MI; Rosenstein RE
J Pineal Res; 2010 May; 48(4):353-64. PubMed ID: 20374442
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potentials of aspirin in glaucomatous optic neuropathy.
Attarzadeh A; Hosseini H; Nowroozizadeh S
Med Hypotheses; 2006; 67(2):375-7. PubMed ID: 16527427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
